| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 06/01/2006 | US20060115480 Disease treatment via antimicrobial peptide inhibitors |
| 06/01/2006 | US20060115464 Use of cardiotrophin to modulate stem cell proliferation |
| 06/01/2006 | US20060115463 Composition of fibroblast or chondrocyte cells transfected or transduced with a gene encoding transforming growth factor beta 1 (TGF- beta 1) or bone morphogenetic protein 2 (BMP-2), and chondrocyte cells that have not been transfected with the gene; generating hyaline cartilage at a target site |
| 06/01/2006 | US20060115462 Direct DNA delivery to bone cells |
| 06/01/2006 | US20060115461 Apparatus and system having dry gene silencing compositions |
| 06/01/2006 | US20060115460 Compositions and methods comprising WNT proteins to promote repair of damaged tissue |
| 06/01/2006 | US20060115456 Replication-competent adenoviral vectors |
| 06/01/2006 | US20060115455 Therapeutic RNAi agents for treating psoriasis |
| 06/01/2006 | US20060115454 Therapeutic RNAi agents for treating restenosis |
| 06/01/2006 | US20060115453 Methods and compositions for treating cellular proliferative diseases |
| 06/01/2006 | DE102004056659A1 New pharmaceutical composition comprising an oligonucleotide that is adapted to target nucleic acids encoding CD40, useful for preventing or treating an inflammatory, immune or autoimmune disorder |
| 06/01/2006 | DE10016881B4 Gezielte Transfektion von Zellen mittels biotinyliertem Dendrimer Targeted transfection of cells using biotinylated dendrimer |
| 06/01/2006 | CA2589561A1 Treatment of neurodegenerative diseases by the use of laptm4a |
| 06/01/2006 | CA2586126A1 Novel shuttle vector |
| 06/01/2006 | CA2584646A1 Treatment of cancer with a combination of an agent that perturbs the egf signaling pathway and an oligonucleotide that reduces clusterin levels |
| 05/31/2006 | EP1662004A1 Method of efficiently constructing growth regulatory recombinant adenovirus vector and kit for the construction thereof |
| 05/31/2006 | EP1662003A2 Paramyxovirus vector for gene transfer to the cardiovascular system |
| 05/31/2006 | EP1661577A1 Therapeutic preparation for hematopoietic disease |
| 05/31/2006 | EP1660687A2 Rnai-based modification of heterochromatin |
| 05/31/2006 | EP1660665A2 Chimaeric vector system |
| 05/31/2006 | EP1660663A2 Methods and compositions for tissue repair |
| 05/31/2006 | EP1660658A2 The use of sirna silencing in the prevention of metastasis |
| 05/31/2006 | EP1660657A1 Interfering rna duplex having blunt-ends and 3'-modifications |
| 05/31/2006 | EP1660633A2 Entrapped stem cells and uses thereof |
| 05/31/2006 | EP1660530A2 Canine specific growth hormone releasing hormone |
| 05/31/2006 | EP1660136A2 Trefoil factor 3 (tff3) as a target for anti-cancer therapy |
| 05/31/2006 | EP1660135A1 Method of treating hepatocellular carcinoma |
| 05/31/2006 | EP1660099A1 Intravascular delivery of non-viral nucleic acid |
| 05/31/2006 | EP1660016A2 Sars nucleic acids, proteins, vaccines, and uses thereof |
| 05/31/2006 | EP1420824B1 Sulfonated chlorines as photosensitizer |
| 05/31/2006 | EP1352061B1 Method for inhibiting the expression of a target gene |
| 05/31/2006 | EP1333845A4 Treatment of t cell disorders |
| 05/31/2006 | EP1313855B1 Truncated bard1 protein, and its diagnostic and therapeutic uses |
| 05/31/2006 | EP1268798B1 Anti-angiogenic properties of vascostatin and fragments or variants thereof |
| 05/31/2006 | EP1231270B1 Novel protein and dna thereof |
| 05/31/2006 | EP1198580B1 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same |
| 05/31/2006 | EP1175489B1 Oligonucleotides containing an antisense sequence stabilised by a secondary structure and pharmaceutical compositions containing same |
| 05/31/2006 | EP1165110B1 Antagonists of hmg1 for treating inflammatory conditions |
| 05/31/2006 | EP1108014B1 Ehrlichia canis protein |
| 05/31/2006 | EP0915156B1 IgA NEPHROPATHY-ASSOCIATED GENE |
| 05/31/2006 | EP0796338B1 Encapsidation cell lines for the transcomplementation of defective retroviral vectors |
| 05/31/2006 | EP0689593B1 Inhibition of selected tumor growth with recombinant viral vector |
| 05/31/2006 | CN1780922A Compositions and methods for the treatment of severe acute respiratory syndrome (SARS) |
| 05/31/2006 | CN1780912A Method for inhibiting cell growth and composition therefor |
| 05/31/2006 | CN1780911A Human antihuman interleukin-18 antibody, fragment thereof and method of using the same |
| 05/31/2006 | CN1780851A Method and carrier complexes for delivering molecules to cells |
| 05/31/2006 | CN1780848A Compositions and methods to initiate or enhance antibody and major-histocompatibility class i or class ii-restricted t cell responses by using immunomodulatory, non-coding RNA motifs |
| 05/31/2006 | CN1780636A Combined use of G-CSF with angiogenetic factor |
| 05/31/2006 | CN1780556A Treating hepatocellular carcinomas using therapeutic viruses |
| 05/31/2006 | CN1780554A Clinically relevant animal model of human breast cancer and VEGF involvement in desmoplastic response, tamoxifen resistance and metastasis |
| 05/31/2006 | CN1778917A RNA interference fragment and its use |
| 05/31/2006 | CN1257986C The method of detecting mutant DSPP gene of hereditary opalescent dentin |
| 05/31/2006 | CN1257976C Improved vaccines |
| 05/31/2006 | CN1257975C Plasmid of recombinant immunotoxin Rantes-DT390 aimed at activating Th1 cell, and its preparing method and use |
| 05/31/2006 | CN1257751C Method for regulating replication of nonreplication adenovirus |
| 05/31/2006 | CN1257750C Glucocorticold enhancement of gene expression |
| 05/30/2006 | US7053207 L-ribo-LNA analogues |
| 05/30/2006 | US7053194 Compositions and methods for p53-mediated repression of gene expression |
| 05/30/2006 | US7053181 Canine and feline B7-2 proteins, compositions and uses thereof |
| 05/30/2006 | US7053062 Compositions and methods for inducing gene expression |
| 05/30/2006 | US7053052 for enhancing immunogenicity activity of tumor cells; tumor/drug targets |
| 05/30/2006 | US7052906 Synthetic transmembrane components |
| 05/30/2006 | US7052904 Hybrid adeno-retroviral vector for the transfection of cells |
| 05/30/2006 | US7052903 Compositions and methods for activating genes of interest |
| 05/30/2006 | US7052899 Toxoplasma gondii proteins, nucleic acid molecules, and uses thereof |
| 05/30/2006 | US7052896 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
| 05/30/2006 | US7052895 nucleotide sequences that code amino acid sequences having hydrolase enzyme activity, used for medical diagnosis, for prophylaxis of diseases and drug screening; bioassay |
| 05/30/2006 | US7052890 Transglutaminase gene products |
| 05/30/2006 | US7052881 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 05/30/2006 | US7052875 stabilization of aqueous solutions of DNA by mixing with citric acid or tartaric acid and atelocollagen, and freeze drying; gene therapy |
| 05/30/2006 | US7052865 culturing specialized cells around blood vessels in the kidneys in the presence of transforming growth factors and glucose, to induce gene expression, then analyzing by suppression subtractive hybridization; diagnostic labels; drug design |
| 05/30/2006 | US7052856 Contacting a cell containing a NELL-1 gene with a test agent; and detecting a change in the expression level of Nell-1 gene as compared to the expression of the NELL-1 gene in a cell that is not contacted with test agent |
| 05/30/2006 | US7052829 Prevascularized constructs for implantation to provide blood perfusion |
| 05/30/2006 | US7052703 T-cell receptorγ alternate reading frame protein, (TARP) and uses thereof |
| 05/30/2006 | US7052692 increasing transcription via inhibition of D-sequence-binding protein (D-BP), which is phosphorylated at tyrosine residues for blocking Adeno-mediated transgene expression in infected cells; inhibiting protein kinase activity; cancer treatment |
| 05/30/2006 | US7052689 Preventing viral replication in cells; obtain cells, incubate with viricide, monitor cells for reduced viral activity |
| 05/26/2006 | WO2006055727A2 MULTICISTRONIC siRNA CONSTRUCTS TO INHIBIT TUMORS |
| 05/26/2006 | WO2006054770A1 Novel map kinase kinase kinase (mapkkk) |
| 05/26/2006 | WO2006054600A1 Novel protein and preventive/remedy for neurodegenerative disease such as polyglutamine disease using the same |
| 05/26/2006 | WO2006054555A1 Medicinal composition for treating cancer or diabetes |
| 05/26/2006 | WO2006053629A1 Retina-specific cells differentiated in vitro from bone marrow stem cells, the production thereof and their use |
| 05/26/2006 | WO2006053430A1 Sirna silencing of apolipoprotein b |
| 05/26/2006 | WO2006022612A3 Methods of using regenerative cells in the treatment of stroke and related diseases and disorders |
| 05/26/2006 | WO2005121370A3 Oligomeric compounds that facilitate risc loading |
| 05/26/2006 | WO2005121369A3 Rna-containing microvesicles and methods therefor |
| 05/26/2006 | WO2005115478A3 Methods and compositions for autism spectrum disorders |
| 05/26/2006 | WO2005100383A3 Novel hiv+ infected cells targeting retroviral vectors and uses thereof for treatment of hiv infection |
| 05/26/2006 | WO2005079533A3 Methods and compositions for mediating gene silencing |
| 05/26/2006 | WO2005074605A3 Recombinant molecular products for expression of heme oxygenase-1, heme oxygenase-2, and/or biliverdin reductase for treatment of neurodegenerative diseases or disorders |
| 05/26/2006 | WO2005069880A3 Modulation of line-1 reverse transcriptase |
| 05/26/2006 | CA2588157A1 Cancer immunotherapy incorporating p53 |
| 05/26/2006 | CA2587411A1 Sirna silencing of apolipoprotein b |
| 05/25/2006 | US20060111562 Human SDF-5 protein and compositions |
| 05/25/2006 | US20060111559 Human G-Protein Chemokine Receptor (CCR5) HDGNR10 |
| 05/25/2006 | US20060111316 Treatment of inflammatory, non-infectious, autoimmune, vasculitic, degenerative vascular, host-v-graft diseases, Alzheimers disease, and amyloidosis using mammalian, dsDNA vaccination |
| 05/25/2006 | US20060111315 Method for inhibition of pathogenic microorganisms |
| 05/25/2006 | US20060111314 Method for treating or preventing metastasis of colorectal cancers |
| 05/25/2006 | US20060111313 modulating calvarial osteoblast differentiation and mineralization in human by altering expression or activity of Nell-1 in human, wherein increased expression or activity of Nell-1 increases osteoblast differentiation or mineralization and decreased expression decreases osteoblast differentiation |
| 05/25/2006 | US20060111312 Antigene locks and therapeutic uses thereof |
| 05/25/2006 | US20060111302 Compositions and methods to reduce mutagenesis |